Comparison Of Clinical Characteristics And Prognosis Of A Series Of Patients From The Spanish Registry Of Mds Diagnosed With Myelodysplastic/Myeloproliferative Neoplasms According To The 2016 Reviewed Classification Of The World Health Organization

Background: The 2016 reviewed classification of the World Health Organisation (WHO) defines a group of myelodysplastic/myeloproliferative neoplasms (MDS/MPN) including the chronic myelomonocytic leukemia (CMML), the myelodyplastic syndrome with ring sideroblasts and thrombocytosis (MDS-RS-T) and the MDS/MPN unclassifiable (MDS/MPN-U). The presence of typical clinical characteristics of MDS and MPN hinders the diagnosis and the prognosis of MDS/MPN-U.